5 Indberettede kliniske og laboratoriemæssige abnormaliteter, blandt voksne patienter, der er behandlet med CANCIDAS (i alt 989), var sædvanligvis milde og krævede sjældent seponering.
5 Reported clinical and laboratory abnormalities among all adult patients treated with CANCIDAS (total 989) were typically mild and rarely led to discontinuation.